Science & Environnement
optional screen reader
AstraZeneca says US data shows COVID-19 vaccine prevents 79% of symptomatic disease
It would be the fourth vaccine authorized for use in the U.S., alongside ones from Pfizer-BioNTech, Moderna, and Johnson & Johnson.
-
‘No evidence’: Vaccine claim rubbished
The chief medical officer says there is no need to suspend the AstraZeneca vaccine rollout, after two government-aligned MPs called for a pause.
-
Russia accused of spreading vaccine disinformation to protect Sputnik V
Russian officials have dismissed accusations that they spread disinformation about rival vaccines as “nonsense”.
-
Johnson & Johnson COVID-19 vaccine, which requires just one shot, is on track to become third allowed for use in US
The J&J vaccine was found in its large trial to be 72% effective in the USA but less effective in South Africa and Latin America, where variants circulated.